hsa-miR-98-5p |
0.00000126 |
−2.271 |
PPARGC1B |
2.893 |
LPS/IL-1 Mediated Inhibition of RXR Function |
hsa-miR-301b-3p |
0.0000118 |
−6.39 |
PPARG |
6.658 |
Adipogenesis pathway, ERK/MAPK Signaling, FXR/RXR Activation, |
hsa-miR-138-5p |
0.00781 |
−5.901 |
PPARGC1A |
8.296 |
AMPK Signaling, Estrogen Receptor Signaling, FXR/RXR Activation |
hsa-miR-27b-3p |
6.84E-07 |
−2.189 |
PPARG |
6.658 |
Adipogenesis pathway, ERK/MAPK Signaling, FXR/RXR Activation, |
hsa-miR-92a-1-5p |
0.00329 |
−5.08 |
PPARGC1A |
8.296 |
AMPK Signaling, Estrogen Receptor Signaling, FXR/RXR Activation |
hsa-miR-92a-1-5p |
0.00329 |
−5.08 |
PPARGC1B |
2.893 |
LPS/IL-1 Mediated Inhibition of RXR Function |
hsa-let-7d-3p |
0.00313 |
−2.569 |
PRKACB |
2.166 |
AMPK Signaling, Amyloid Processing, Androgen Signaling |
hsa-miR-128-3p |
0.00111 |
−2.576 |
PRKD1 |
2.769 |
14-3-3-mediated Signaling, Aldosterone Signaling in Epithelial Cells, Androgen Signaling |
hsa-miR-138-5p |
0.00781 |
−5.901 |
GNG2 |
2.87 |
Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2 |
hsa-miR-148b-3p |
0.00000885 |
−2.159 |
MRAS |
2.83 |
14-3-3-mediated Signaling, Actin Cytoskeleton Signaling |
hsa-miR-182-5p |
0.0000627 |
−2.718 |
PRKACB |
2.166 |
AMPK Signaling, Amyloid Processing, Androgen Signaling, Axonal Guidance Signaling |
hsa-miR-3656 |
0.00000101 |
5.481 |
POLR2L |
−1.226 |
Androgen Signaling, Assembly of RNA Polymerase II Complex, CREB Signaling in Neurons |
hsa-miR-539-3p |
0.00902 |
2.178 |
GNA14 |
−2.398 |
Androgen Signaling, Axonal Guidance Signaling |
hsa-miR-487b-3p |
0.00000964 |
2.389 |
SRY |
−1.544 |
Androgen Signaling, Neuroprotective Role of THOP1 in Alzheimer’s Disease |
hsa-miR-615-3p |
0.00922 |
−5.078 |
AR |
5.175 |
Androgen Signaling |
hsa-miR-7977 |
0.00418 |
−2.261 |
GNG2 |
2.87 |
Androgen Signaling, Antiproliferative Role of Somatostatin Receptor 2, Axonal Guidance Signaling |